A Phase 2 Study Using Metronomic Trabectedin, Gemcitabine, and Dacarbazine for Advanced Leiomyosarcoma
Condition: Leiomyosarcoma Intervention: Drug: Trabectedin Sponsor: Sarcoma Oncology Research Center, LLC Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials